Unlocking Drug Discovery: The Power of AS-MS in Protein-Ligand Binding Studies
With over 22 years of experience at Merck, I specialize in affinity selection-mass spectrometry (AS-MS) to elucidate protein-ligand binding mechanisms. Discover how AS-MS can enhance drug discovery by analyzing diverse ligand mixtures and identifying critical binding sites for effective therapeutic development.
5/8/20241 min read
Innovative Drug Discovery